Passa ai contenuti principali
Logo
Accelerating Clinical Trials in the EU

ACT EU workplan for 2025-2026 published

  • Articolo
  • 20 gennaio 2025
  • Agenzia europea per i medicinali
  • 1 min di lettura

The ACT EU workplan for 2025-2026 is now available. 

The revised workplan highlights ACT EU’s areas of focus over the next two years, reflecting the feedback received through the multi-stakeholder platform advisory group and other channels: 

  • The operation of the Clinical Trials Regulation.
  • Maximising the impact of clinical trials.
  • Clinical trials in public health emergencies.

Clinical trial analytics, training, and communication remain integral to ACT EU’s work, and interlinked with all other activities. 

For more details, see: ACT EU workplan 2025-2026

Data di pubblicazione
20 gennaio 2025
Autore
Agenzia europea per i medicinali